PulseMagic™ TrueForce™ PAF NMPA Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT07720557
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Registry
-
NCT07720557
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07720557. Allocation not applicable; no masking; primary purpose treatment. Start 2026-07-10 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PulseMagic™ TrueForce™ PAF NMPA Study
- Acronym
- PFATrueForce
- Condition
- Atrial Fibrillation (AF)
- Condition
- Paroxysmal AF
- Condition
- Drug Refractory Paroxysmal Atrial Fibrillation
- Condition
- Atrial Arrhythmia
- Intervention (Device)
- PFA Ablation catheter
- Lead sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
Record details
- Record id
cardio:ct-nct07720557- Content hash
a1e80ed2f808fa832fadb8fe36009027f3fbc4840578963a392025d3e870ca49